The First Year of Agentic AI: AI Agents Enter the Core of Operations
Published on the 31st of May, 2025 on Sin Chew Daily The First Year of
Published on Sin Chew Daily on the 9th June 2025
AI Accelerates mRNA Medical Research: Human Lifespan May Extend by 10 Years
In recent years, mRNA technology has emerged as one of the most revolutionary forces in modern medicine, especially after the global outbreak of COVID-19. As mRNA-based vaccines quickly entered development and deployment, their potential in medical science became evident. Looking ahead, combining Artificial General Intelligence (AGI) and mRNA technology could lead to major medical breakthroughs. Experts predict that integrating AI into mRNA medical research could extend the average human lifespan by 10 years.
Current generative AI platforms such as OpenAI’s ChatGPT are widely known. However, the next stage—Artificial General Intelligence (AGI)—refers to systems capable of human-like general reasoning and learning abilities. In mRNA research, AGI offers new methods for rapid sequence generation, screening, and optimization, accelerating the pace of discovery. Here’s how AGI is contributing to the advancement of mRNA research:
AGI possesses the ability to understand natural language, access vast scientific databases, and perform large-scale semantic analysis. This allows it to assist scientists in rapidly identifying mRNA sequences, predicting protein structures, and matching diseases with therapeutic strategies. For instance, AGI can help develop mRNA vaccines or therapies more efficiently by analyzing biomedical texts and experimental data.
Designing stable and highly expressed mRNA sequences is a core challenge. AGI can optimize sequence codons, structures, and untranslated regions (UTRs), adjusting RNA folding to reduce immune responses while increasing mRNA stability and protein expression levels.
mRNA production includes steps like in vitro transcription (IVT) and purification. AGI can be used to optimize these processes. For example, by analyzing different IVT system combinations, AGI can improve yield and purity. It can also simulate cell culture environments to enhance production strategies for both mRNA and small interfering RNA (siRNA).
AGI’s key strength is its ability to simulate complex biological systems. In mRNA sequence design, researchers can use AGI to model biological pathways, immune responses, and pharmacokinetics. Tools like Nvidia’s Uni-Dock platform use GPUs to simulate tens of thousands of molecular interactions daily, enabling precise targeting and reduced side effects.
Through AI-aided structure prediction and energy minimization calculations, researchers can redesign mRNA structures to improve immune response evasion and increase translation efficiency.
Lipid nanoparticle (LNP) systems are crucial for delivering mRNA vaccines. AGI can assist in optimizing the composition, size, and encapsulation efficiency of LNPs, improving the bioavailability of mRNA drugs. For example, AGI can analyze how mRNA behaves after entering the body to improve LNP formulation.
To enable AGI in mRNA research, enormous computing power is required. Nvidia GPUs play a vital role in powering AGI systems to conduct massive-scale data analysis and simulation. For instance, Nvidia launched Clara for Drug Discovery, which uses deep learning and GPU acceleration to simulate molecular structures and screen candidate drugs at high speed.
Additionally, Nvidia’s DGX AI supercomputing platform and Illumina’s sequencing platforms are crucial tools that provide AGI with the capability to analyze genome and transcriptome data in real time.
The success of COVID-19 mRNA vaccines showcased the potential of mRNA technology. With AGI now entering the scene, a new age of AI-powered medicine is emerging. From target prediction to structure modeling and production optimization, AGI combined with powerful GPUs may become the next game-changing force in drug development.
For example, AGI helped analyze the genetic sequence of the SARS-CoV-2 virus and identified the spike protein as a vaccine target—speeding up the development process dramatically.
The integration of AGI and mRNA research marks a revolutionary step for biomedicine. Experts believe this combination could lead to precision medicine and next-generation vaccines, as well as personalized therapies. With technological advancements, humans may indeed live longer, healthier lives—with an estimated lifespan extension of up to 10 years.
Published on the 31st of May, 2025 on Sin Chew Daily The First Year of
Published on Sin Chew Daily on the 9th June 2025 AI Accelerates mRNA Medical Research:
— A Veteran SEO’s View on Change and Continuity published on Sin Chew Daily on